Skip to main content

Mulryne, Roussanov Quoted in The Pink Sheet on Revised EU Guidelines for Duplicate Marketing Authorizations

March 22, 2021

Life Sciences and Healthcare Regulatory partners Jacqueline Mulryne and Alexander Roussanov were quoted in an article from The Pink Sheet, "New EU Approach On Duplicate Marketing Authorizations Prompts Questions." The article discusses the European Commission's revised guidance on duplicate marketing authorizations for chemical medicinal products from "originator companies" and the potential effects the changes could have on availability of biosimilar medicines.

» Read the full article (subscription required).